Best Paper Award

Dear Colleagues,

We are pleased to announce the “Pharmaceuticals 2022 Best Paper Award” for research and review articles published in Pharmaceuticals from 1 January 2022 to 31 December 2022. One review and two research articles will receive an award each. The papers will be selected after a thorough evaluation by the journal Award Committee, led by the Editor-in-Chief, Prof. Dr. Amélia Pilar Rauter.

Eligibility for the Award:
– Papers published from 1 January 2022 to 31 December 2022;
– Open to all career levels;
– Both regular and Special Issue submissions will be considered.

Selection Criteria:
The papers will be selected by the journal Award Committee according to the following criteria:
– Scientific merit and broad impact;
– Originality of the research objectives and/or the ideas presented;
– Creativity of the study design or uniqueness of the approaches and concepts;
– Clarity of presentation;
– Citations and downloads.

The Prize:
– One review award: CHF 400 and a chance to publish a paper free of charge in Pharmaceuticals in 2024 after peer review;
– Two research article awards: CHF 400 and a chance to publish a paper free of charge in Pharmaceuticals in 2024 after peer review;
– Each winner will also receive a certificate.
The winners will be announced on the journal website in February 2024.

Kind regards,
Pharmaceuticals Editorial Office
 
Pharmaceuticals Best Paper Award
 

Eligibility and Requirements

– All papers published in Pharmaceuticals will be eligible (both regular and Special Issue submissions).

Selection Criteria

– Scientific merit and broad impact;
– Originality of the research objectives and/or the ideas presented;
– Creativity of the study design or uniqueness of the approaches and concepts;
– Clarity of presentation;
– Citations and downloads.

 
Past Winners
 
Year: 

Winner

24 pages, 886 KiB  
Review
Bone Tissue Engineering in the Treatment of Bone Defects
by Nannan Xue, Xiaofeng Ding, Rizhong Huang, Ruihan Jiang, Heyan Huang, Xin Pan, Wen Min, Jun Chen, Jin-Ao Duan, Pei Liu and Yiwei Wang
Pharmaceuticals 2022, 15(7), 879; https://doi.org/10.3390/ph15070879 - 17 Jul 2022
25 pages, 2081 KiB  
Article
Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2
by Fakry F. Mohamed, Darisuren Anhlan, Michael Schöfbänker, André Schreiber, Nica Classen, Andreas Hensel, Georg Hempel, Wolfgang Scholz, Joachim Kühn, Eike R. Hrincius and Stephan Ludwig
Pharmaceuticals 2022, 15(5), 530; https://doi.org/10.3390/ph15050530 - 25 Apr 2022
25 pages, 2202 KiB  
Article
LC–MS/MS Phytochemical Profiling, Antioxidant Activity, and Cytotoxicity of the Ethanolic Extract of Atriplex halimus L. against Breast Cancer Cell Lines: Computational Studies and Experimental Validation
by Amine Elbouzidi, Hayat Ouassou, Marouane Aherkou, Loubna Kharchoufa, Nada Meskali, Abdellah Baraich, Hamza Mechchate, Mohamed Bouhrim, Abderrazak Idir, Christophe Hano, Hassan Zrouri and Mohamed Addi
Pharmaceuticals 2022, 15(9), 1156; https://doi.org/10.3390/ph15091156 - 16 Sep 2022

Award Committee

Prof. Serge Mordon Chairman
INSERM
Prof. François Dufrasne
Microbiology, Bioorganic and Macromolecular Chemistry, Drug Research and Development Faculté de Pharmacie - Université Libre de Bruxelles
Dr. Elena Y. Enioutina
Division of Clinical Pharmacology, Pediatrics, School of Medicine, University of Utah
Dr. Eleni Gavriilaki
G Papanicolaou Hospital
Back to TopTop